TotalMarketCap

Odyssey Therapeutics

ODTXNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$904.878 M

$18.83 -3.46%

Close of 6 Nov 2026

As of 6 Nov 2026, Odyssey Therapeutics (ODTX) has a market capitalization of $904.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

48,067,877

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #45Vor BiopharmaVOR$1.15B
  2. #46ImmaticsIMTX$930.0M
  3. #47Odyssey TherapeuticsODTX$904.9M
  4. #48Monte Rosa TherapeuticsGLUE$872.8M
  5. #49MeiraGTxMGTX$818.2M

What if Odyssey Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$587,437.51

Per share 31,205× higher

Bitcoin $1.53T

$31,785.22

Per share 1,688× higher

Apple $5.02T

$104,347.91

Per share 5,543× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Odyssey Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.